Compare AstraZeneca plc (AZN) vs Jabil Inc (JBL) Price & Performance

AstraZeneca plcTrade

Jabil IncTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs Jabil Inc — how do they compare? AstraZeneca plc trades at $158 (market cap $248.14B), while Jabil Inc trades at $362 (market cap $37.37B). The key difference: AstraZeneca plc is far larger — about 6.6× Jabil Inc's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.

	AZN	JBL
Market Cap	$248.14B	$37.37B
Sector	Health	Technology
52-Week High	$209.48	$385.50
52-Week Low	$147.06	$192.49
Enterprise Value	$275.41B	$39.90B
Dividend Yield	2.01%	0.09%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AZN

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

JBL

UBS upgrades Jabil, citing AI, healthcare, and automation growth with a $430 price target.Proactive Investors · 18 hours agoBullish Jabil expands into full data center services, targeting $40B revenue and $13.6B AI revenue by 2026.Seeking Alpha · 1 day agoBullish View details →

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

About Jabil Inc

Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.